Displaying drugs 201 - 225 of 12628 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Vorozole | 324.77 C16H13ClN6 |  | Not Annotated | Aromatase Inhibitors |
| Vorolanib | 439.491 C23H26FN5O3 |  | Vorolanib is under investigation in clinical trial NCT03904719 (CM082 and JS001 in Patients With Advanced Small-cell Lung Cancer (SCLC)). | Protein Kinase Inhibitors |
| Vorinostat | 264.3202 C14H20N2O3 |  | A histone deacetylase (HDAC) inhibitor used for the treatment of cutaneous manifestations in patients with progressive, persistent, or recurrent cutaneous T- cell lymphoma (CTCL) following prior systemic therapies. | Histone deacetylase (HDAC) inhibitors |
| Voriconazole | 349.3105 C16H14F3N5O |  | A triazole compound used to treat fungal infections. | Triazole and tetrazole derivatives / Triazole Derivatives |
| Vorasidenib | 414.74 C14H13ClF6N6 |  | Not Available | Amines / Polyamines |
| Vorapaxar | 492.5817 C29H33FN2O4 |  | A platelet aggregation inhibitor used to reduce thrombotic cardiovascular events in patients with a history of myocardial infarction (MI) or peripheral arterial disease (PAD). | Platelet Aggregation Inhibitors Excl. Heparin |
| Vonoprazan | 345.39 C17H16FN3O2S |  | A potassium-competitive acid blocker used in the treatment of acid-related disorders and as an adjunct to Helicobacter pylori eradication. | Alimentary Tract and Metabolism / Amides / Cytochrome P-450 CYP2B6 Substrates / Cytochrome P-450 CYP2C19 Inhibitors / Cytochrome P-450 CYP2C19 inhibitors (strength unknown) / Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP2D6 Substrates / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A5 Substrates / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Drugs for Acid Related Disorders / Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord) / Gastric Acid Lowering Agents / P-glycoprotein inhibitors / Potassium-competitive Acid Blockers / Sulfones / Sulfur Compounds |
| Volixibat | 805.96 C38H51N3O12S2 |  | Volixibat is an investigational drug that has not been approved for use in any conditions. | Lipid Regulating Agents |
| Volinanserin | 373.468 C22H28FNO3 |  | Volinanserin is under investigation in clinical trial NCT00464243 (Efficacy and Safety of Volinanserin on Sleep Maintenance Insomnia - Polysomnographic Study). | Serotonin Receptor Antagonists |
| Volasertib | 618.8126 C34H50N8O3 |  | Volasertib has been used in trials studying the treatment of Leukemia, Neoplasms, Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, and Leukemia, Monocytic, Acute, among others. | Antineoplastic Agents / Heterocyclic Compounds, Fused-Ring |
| Voglibose | 267.2762 C10H21NO7 |  | An alpha-glucosidase inhibitor indicated in the management of postprandial blood glucose in patients with type II diabetes. | Glycoside Hydrolase Inhibitors |
| Vofopitant | 432.451 C21H23F3N6O |  | Vofopitant has been used in trials studying the treatment of PTSD, Primary Insomnia, and Sleep Initiation and Maintenance Disorders. | Antiemetics / Neurokinin-1 Receptor Antagonists |
| Vodudeutentan | 643.822 C34H51N5O7 |  | Not Available | Not Available |
| Vodobatinib | 453.93 C27H20ClN3O2 |  | Not Annotated | Not Annotated |
| Voclosporin | 1214.646 C63H111N11O12 |  | A calcineurin inhibitor for the treatment of lupus nephritis (LN) in patients diagnosed with systemic lupus erythematosus (SLE). | Calcineurin Inhibitors |
| Vocacapsaicin | 459.631 C26H41N3O4 |  | Not Available | Not Available |
| Voacamine | 704.8968 C43H52N4O5 |  | For the treatment of malaria. Also under investigation for the modulation of multidrug resistance in cancer cells. | Alkaloids / Heterocyclic Compounds, Fused-Ring / Indole Alkaloids / Indoles / Indolizidines / Indolizines / P-glycoprotein inhibitors / Secologanin Tryptamine Alkaloids |
| VMD-928 | 524.621 C31H32N4O4 |  | Not Annotated | Not Annotated |
| VM4-037 | 620.67 C26H29FN6O7S2 |  | VM4-037 is under investigation in clinical trial NCT00884520 (An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037). | Fluorine Radioisotopes |
| VLX-1570 | 469.401 C23H17F2N3O6 |  | VLX-1570 is under investigation in clinical trial NCT02372240 (A Study of VLX1570 and Dexamethasone in Myeloma Patients). | Benzene Derivatives |
| VLX-1005 | 441.52 C21H19N3O4S2 |  | Not Annotated | Amides / Benzene Derivatives / Sulfonamides / Sulfones / Sulfur Compounds |
| VLTS-589 | Not Available |  | Investigated for use/treatment in peripheral vascular disease. | Not Available |
| VL-2397 | 914.951 C40H59AlN10O13 |  | Not Annotated | Antifungal Agents |
| VK-2809 | 514.98 C28H32ClO5P |  | VK-2809 is under investigation in clinical trial NCT02927184 (Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease). | Organophosphorus Compounds |
| VK-0214 | 412.422 C23H25O5P |  | Not Annotated | Not Annotated |
Displaying drugs 201 - 225 of 12628 in total